Elsevier

Brain and Development

Volume 44, Issue 1, January 2022, Pages 44-49
Brain and Development

Case Report
Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy

https://doi.org/10.1016/j.braindev.2021.08.006Get rights and content

Abstract

Background

Ferric chelate reductase 1 like (FRRS1L) encephalopathy is a rare cause of developmental and epileptic encephalopathy. Only a few cases have been reported thus far and seizures tend to be drug refractory. We report an additional case to highlight the good seizure response to sulthiame.

Case report

A boy from non-consanguineous parents presented with history of ‘abnormal movements’ from 7 months of age. At one year of age, video electroencephalogram (EEG) monitoring demonstrated the ‘abnormal movements’ to be clonic seizures. Valproate, lamotrigine and clobazam combination were only partially effective at reducing the seizures. Repeat EEG at 1 year 8 months old revealed a continuous spikes-and-waves during slow sleep (CSWS) pattern, prompting a trial of sulthiame. After 2 weeks of sulthiame, seizures ceased completely. The clonic seizures recurred at age 4 years when sulthiame supply was interrupted, but the seizures promptly remitted following sulthiame’s resumption. Subtle choreiform movements appeared from age one year and later became more prominent. Whole exome sequencing (WES) identified a homozygous novel variant (nonsense) in the FRRS1L gene (NM_014334.3: c.670C>T:p.Gln224*). He has been seizure free since 4 years of age but remained profoundly delayed.

Conclusion

Sulthiame may have a role in the early treatment of seizures in children with refractory epilepsy due to FRRS1L mutation.

Introduction

Developmental and epileptic encephalopathy is a newly coined term to describe patients in whom developmental impairments result from combination of seizures, electroencephalogram (EEG) abnormalities and the underlying disease [1]. They comprise a heterogenous group of conditions, many of which start in infancy and have underlying genetic abnormalities. Ferric chelate reductase 1 like (FRRS1L) encephalopathy (Early Infantile Epileptic Encephalopathy-37) is a rare example of this condition. Only 14 children from five families have been reported with FRRS1L gene mutation. All had epilepsy, movement disorders and severe developmental delay or regression [2], [3].

Seizures in FRRS1L encephalopathy were mostly refractory to anti-epileptic drugs (AEDs). Various seizure types were described by Madeo et al. [2], including clonic, hemi-clonic, generalized tonic-clonic, spasms and ‘multifocal’ seizure types. Detailed EEG findings were reported in two of the patients from Shaheen’s series [3]; one girl displayed a continuous spikes-and-waves during slow sleep (CSWS) pattern and her brother showed stereotyped occipital spike waves with fixation off phenomenon [4].

Herein we report a patient with FRRS1L encephalopathy, describing the seizures and clinical phenotype, EEG evolution and response to AEDs, highlighting the good response to sulthiame.

Section snippets

Case report

This boy was the first born from a non-consanguineous Malay couple. He was born term, weighed 3.14 kg at birth (at 25th centile) with head circumference (COH) of 32 cm (on the 3rd centile). He had uneventful antenatal and neonatal period but at 6 months old was noted to be globally delayed as he could not fix or follow objects, nor could he reach for objects or roll over. He started to have abnormal movement involving the limbs starting at the age of 7 months. These were repetitive movements of

Discussion

Our patient with FRRS1L encephalopathy displayed many clinical features described in the literature, namely the infantile onset refractory seizure, severe developmental delay and evolving movement disorder. In addition, our patient showed severe failure to thrive and microcephaly. Of particular interest, the seizures in our patient responded well to sulthiame, an observation not reported previously.

In the largest case series thus far, Madeo et al. [2] identified four different homozygous

Conclusion

Sulthiame may have a role in the early treatment of seizures in children with refractory epilepsy due FRRS1L mutation. It remains to be seen if sulthiame can also be effective for controlling seizures in other EIEE with CSWS patterns.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

The authors would like to acknowledge the patient and his caregivers for their contribution and permission to publish patient’s video. The authors also like to thank Eriko Koshimizu, Satoko Miyatake and Naomichi Matsumoto, Department of Human Genetics, Yokohama City University Graduate School of Medicine for performing the whole exome sequencing.

References (13)

  • I.E. Scheffer et al.

    Deciphering the concepts behind “Epileptic encephalopathy” and “Developmental and epileptic encephalopathy”

    Eur J Paediatr Neuro

    (2020)
  • M. Madeo et al.

    Loss-of-function mutations in FRRS1L lead to an epileptic-dyskinetic encephalopathy

    Am J Hum Genet

    (2016)
  • R. Shaheen et al.

    Epileptic encephalopathy with continuous spike-and-wave during sleep maps to a homozygous truncating mutation in AMPA receptor component FRRS1L

    Clin Genet

    (2016)
  • I.Y. Saadeldin et al.

    Coexistence of epileptic encephalopathy with continuous spike-and-wave during sleep, atypical benign partial epilepsy, and fixation-off sensitivity in two siblings

    Epilepsy Behav

    (2011)
  • B. Sonnek et al.

    Clinical spectrum and treatment outcome of 95 children with continuous spikes and waves during sleep (CSWS)

    Eur J Paediatr Neurol

    (2021)
  • Stewart M, Lau P, Banks G, Bains RS, Castroflorio E, Oliver PL et al. Loss of FRRS1L disrupts synaptic AMPA receptor...
There are more references available in the full text version of this article.

Cited by (5)

View full text